Bharat Immunologicals & Biologicals Corporation Cash Flow Annual

Trade
BSE: 524663 | NSE: - | ISIN: INE994B01014 | Sector: Major Drugs
23.63 +0.01 (0.04%)Updated : 25 Nov 2024
Fiscal Period2023202220212020
Period End DateMar 23Mar 22Mar 21Mar 20
Net Income/ Starting Line -22.85-9.69-14.20-14.20
Depreciation/ Depletion 0.150.210.240.24
Non- Cash Items 6.585.063.843.84
Changesin Working Capital 27.02-37.7044.2144.21
Cashfrom Operating Activities 10.89-42.1234.0834.08
Capital Expenditures 0.000.000.000.00
Other Investing Cash Flow Items Total 0.460.530.910.91
Cashfrom Investing Activities 0.460.530.910.91
Financing Cash Flow Items -7.04-5.59-5.23-5.23
Issuance( Retirement)of Debt Net -7.6750.59-29.18-29.18
Cashfrom Financing Activities -14.7145.00-34.41-34.41
Net Changein Cash -3.363.420.580.58
Cash Interest Paid 7.045.594.744.74
*All figures in crores except per share values
Recommended For You
Trending Stocks
3,753.25+148.70(4.13%)
1,784.60+38.65(2.21%)
1,733.95-13.75 (-0.79%)
2,460.60-18.40 (-0.74%)
HomeMarketsPremiumInstant LoanMint Shorts